[Retracted] Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy

Figure 7

(a) TLR-2 inhibition by TLR-2 neutralizing antibody attenuates downstream inflammatory biomediators: HMVRECs were serum starved for 2 hours and treated with 100 and 200 nM TLR-2 neutralizing antibody for 2 hours. Thereafter 5.5 and 25 mM glucose treatments were performed as described in Figure 3. (I) NF-B, (II) TNF-, (III) IL-8, and (IV) MCP-1 levels are significantly decreased upon TLR-2 inhibition compared to HG treatment. versus control, versus 25 mM, and versus 100 nM. (b) Cell adhesion molecules ICAM-1 and VCAM-1 attenuation upon TLR-2 neutralizing antibody treatment. HMVRECs were serum starved for 2 hours and treated with 100 and 200 nM TLR-2 neutralizing antibody for 2 hours. Thereafter 5.5 and 25 mM glucose treatments were performed as described in Figure 4. Adhesion molecules (I) ICAM-1 and (II) VCAM-1 levels are significantly decreased upon TLR-2 inhibition. versus control and versus 25 mM. (III) Adhesion assay showing decreased cell adhesion with TLR-2 inhibition. versus control and versus 25 mM.

(a)

(b)